Paromomycin sulfate dosage and administration: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Paromomycin sulfate}} {{CMG}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PAROMOMYCIN SULFATE CAPSULE [CARACO PHARMACEUTICAL LAB...") |
Gerald Chi (talk | contribs) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Paromomycin sulfate}} | {{Paromomycin sulfate}} | ||
{{CMG}} | {{CMG}} | ||
==Dosage Aand Administration== | |||
===Intestinal Amebiasis=== | |||
======Adults and Children====== | |||
Usual dose—25 to 35 mg/kg body weight daily, administered in three doses with meals, for five to ten days. | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PAROMOMYCIN SULFATE CAPSULE [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22494bde-a53e-4b3c-a89b-0ccda341f28f | publisher = | date = | accessdate = }}</ref> | ===Management of Hepatic Coma=== | ||
======Adults====== | |||
Usual dose—4 g daily in divided doses, given at regular intervals for five to six days.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PAROMOMYCIN SULFATE CAPSULE [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22494bde-a53e-4b3c-a89b-0ccda341f28f | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 00:48, 31 December 2013
| Paromomycin Sulfate |
|---|
| PAROMOMYCIN SULFATE capsule® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosage Aand Administration
Intestinal Amebiasis
Adults and Children
Usual dose—25 to 35 mg/kg body weight daily, administered in three doses with meals, for five to ten days.
Management of Hepatic Coma
Adults
Usual dose—4 g daily in divided doses, given at regular intervals for five to six days.[1]
References
Adapted from the FDA Package Insert.